[HMD BioMedical] May 2026 Revenue reaches NT$139 million (YoY -3.0%)
NQ Score
57/100
N1 Content Completeness
60
AI Summary (NQ-processed)
HMD BioMedical (4155) announced its consolidated revenue for May 2026 at NT$139.23 million, representing a 3.0% decrease compared to the same period last year.
AI Analysis
Frequently Asked Questions
- Q: What was HMD BioMedical's revenue in May 2026?
- A: The revenue for May 2026 was NT$139,231 thousand (approx. NT$139 million).
- Q: How did May 2026 revenue compare to the previous year?
- A: It decreased by 3.0% compared to the same month last year.
- Q: What is HMD BioMedical's core business?
- A: It specializes in the research, development, and manufacturing of blood glucose monitoring systems.